Conservative Management of Giant Pyogenic Granuloma Post Strabismus Surgery: A Case Report and Literature Review (original) (raw)
Related papers
Pyogenic granuloma after a non-sutured transconjunctival blepharoplasty in the lower eyelid
European Journal of Plastic Surgery, 2019
Pyogenic granuloma (PG) is a vasoproliferative inflammatory response composed of granulation tissue. The pathogenesis is not entirely clear. Pyogenic granuloma was found involving the skin or mucosal surfaces, and it is associated with tissue irritation or inflammation. Pyogenic granuloma as a complication after blepharoplasty is uncommon. The treatment is simple and saves the patients from the discomfort caused by the lesion. Surgical excision is effective in patients who do not improve with a local application of steroids. We describe two cases of uncommon pyogenic granuloma occurring after lower transconjunctival blepharoplasty, with no suture and alert ophthalmologists and oculoplastic surgeons to the possibility of encountering and treating these lesions. Level of Evidence: Level V, therapeutic/diagnostic study.
Pyogenic Granuloma - A Simple Treatment Approach with Sclerotherapy
2021
Pyogenic granuloma (PG) is a benign exophytic vascular tumor, which is actually a reactive inflammatory mass of blood vessels with few fibroblasts within the mucosa or skin, was first reported by Hullihen in 1844. Variety of treatment options such as surgical excision, laser treatment, electrodessication, chemical cautery, cryosurgery, intralesional steroid injection etc. are available, but many a times, recurrence has also been reported. Sclerotherapy is defined as the "targeted elimination of small vessels, varicose veins and vascular anomalies by the injection of a "sclerosant". It offers an alternative to conventional methods like surgery, lasers, radio frequency ablation and electrodesiccation procedure with success and less chance of recurrences. Herein, we present a case of 22 years old female with a clinical diagnosis of PG, treated with intralesional 0.2 ml of 3% sodium tetradecyl sulfate (STS). The lesion healed completely at the patient's 3 rd visit and recurrence was not reported till the patient was followed up for one year.
Resolution of recalcitrant pyogenic granuloma with laser, corticosteroid, and timolol therapy
Dermatology online journal
A pyogenic granuloma (PG) is a rapidly growing benign vascular tumor that can be found on the skin or subcutaneous tissue. While some pyogenic granulomas may resolve spontaneously, most have a tendency to bleed easily and require treatment. Current therapeutic modalities include topical imiquimod, cryotherapy, electrodessication, curettage, excision, laser therapy, sclerotherapy, and microembolization. We report a recalcitrant case of chronic pyogenic granuloma occurring on the scalp of a healthy young male which was unresponsive to conventional surgical and non-surgical modalities. Ultimately, aggressive laser therapy, intralesional triamcinolone acetonide injections, and topical timolol application led to complete resolution and healing.
Treatment of Pyogenic Granuloma with a Sclerosing Agent
Dermatologic Surgery, 2001
background. Pyogenic granulomas have been treated by cryosurgery, curettage, electrodesiccation, chemical cauterization, and laser surgery. The therapeutic effects of these conservative treatments are limited, however. objective. In this study, the efficacy of a sclerosing agent (monoethanolamine oleate) was evaluated for the treatment of pyogenic granuloma. methods. Pyogenic granuloma was treated by local injection of the monoethanolamine oleate solution in nine patients who were from 1 to 57 years of age (median 18 years). The treatment effect was determined by physical examination. results. All lesions were removed completely with no recurrence, and scars were inconspicuous in all cases. Complications occurred in only one patient who complained of pain due to an avoidable injection of excess solution. conclusion. Sclerotherapy with monoethanolamine oleate is effective in the treatment of pyogenic granuloma and offers an alternative to conventional methods in cases for which conservative treatment is preferable.
Sclerotherapy: a bloodless approach in treatment of pyogenic granuloma in children
International Journal of Dermatology, 2020
Pyogenic granuloma (PG) is a common, acquired tumor-like growth occurring on skin/mucous membranes. It is prevalent in the pediatric age group. It is benign in nature and is caused by chronic low grade trauma. It presents as pink to red elevated pedunculated or sessile mass. There are various treatment modalities including surgery, cryotherapy, laser, electrocautery, etc. However, the therapeutic effects are limited with high recurrence rates. The use of sclerotherapy for the treatment of pyogenic granuloma in children is not commonly reported. We present a case of PG on the scalp successfully treated with intralesional injection of sodium tetradecyl sulfate.
Pediatric dermatology, 2018
Pyogenic granuloma (PG) is a common, acquired, benign vascular neoplasm of the skin and mucous membranes. It occurs most often in children and adolescents. First-line treatment options for PG are based on destructive approaches. Pain, permanent scarring, and pigmentation are potential complications of these therapies. This single-arm, open-label, prospective study evaluated the efficacy of topical propranolol for treatment of PGs in children. All patients clinically diagnosed with cutaneous PG consecutively at the Dermatology Pediatric Outpatient Service of the University of Bologna from January 2010 to December 2010 received a compounded formulation of propranolol ointment 1%. We found propranolol ointment to be effective in consecutive patients; 59.0% completely regressed in a mean of 66 days, 18.2% remained stable, and 22.7% did not respond. No side effects (eg, skin irritation, allergy, bleeding) were observed. Topical propranolol ointment 1% with occlusion appears to be an effe...
Case Report: Corneal Pyogenic Granuloma: Rare Complication of Infectious Keratitis
Ethiopian Journal of Health Sciences, 2014
BACKGROUND: Pyogenic granuloma is an excessive proliferation of granulation tissue that usually develops after minor trauma or surgery. Ocular involvement usually happens on the external surface and cornea is rarely involved. The objective of our report is to describe the clinicopathological feature of this rare disease and give insight on clinical features that help in the diagnosis. CASE REPORT: This report presents a case of a four year old child who had fleshy growth of one week duration on the right eye after seven weeks of pain and redness. Slit lamp examination showed vascularized central corneal mass with surrounding stromal infiltrates. The mass was excised, and histopathological examination confirmed pyogenic granuloma of the cornea. CONCLUSION: Corneal pyogenic granuloma could be a rare complication of infectious keratitis. Therefore, it should be considered as a differential diagnosis in corneal mass especially after an infection or trauma.
Pyogenic Granuloma Formation Following Ahmed Valve Glaucoma Implant
Journal of Glaucoma, 2019
Ocular pyogenic granuloma is a benign tumor seen after ocular insult secondary to ocular surgeries, trauma or infection. Although benign, intervention is sometimes necessary. Previous authors have reported pyogenic granuloma formation following oculoplastic surgeries. We report a pyogenic granuloma after an Ahmed glaucoma valve implantation. A 65-year-old gentleman presented with right eye redness associated with pain and swelling~2 months after Ahmed glaucoma valve implantation. Examination found a sessile growth on the tube extruding puss with signs of endophthalmitis. The glaucoma drainage device was explanted and culture results grew Staphylococcus aureus. This article discusses the formation of pyogenic granuloma on a glaucoma drainage device and its management.